Sign up
Quantellect · Congress · Trade Detail
NASDAQ: REGNRegeneron Pharmaceuticals Inc
RepublicanHouse

Michael T. McCaul bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 65 trades in Regeneron Pharmaceuticals Inc (REGN) since 2013, 46 purchases and 19 sales, worth an estimated $3.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Michael T. McCaul bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on December 27, 2013. Since that trade, REGN is up +153.09% against the S&P 500 up +388.48%, an outperformance of -235.39%.

Across these filings, Michael T. McCaul has been a net buyer of REGN (a buy-to-sell ratio of 2.42). The most recent disclosed REGN transaction shown was dated May 7, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

REGN trades
65
Disclosed Vol
$3.1M
Buys
46
71%
Sells
19
29%
Buy / Sell
2.42
ratio
First → Last
2013–2019

Michael T. McCaul's REGN trades vs the price

REGN is up +153.09% since Michael T. McCaul bought on December 27, 2013, versus +388.48% for the S&P 500.

Performance since this trade

Price change since trade
+153.09%
S&P 500 change since trade
+388.48%
Outperformance vs S&P 500
-235.39%

All Michael T. McCaul REGN trades

TradedTypeSizeReturnEst. profit
May 7, 2019SELL$319.76+117.48%
May 7, 2019SELL$319.76+117.48%
May 6, 2019SELL$341.41+103.69%
May 6, 2019BUY$341.41+103.69%+$77K
May 6, 2019SELL$341.41+103.69%
April 29, 2019BUY$341.33+103.74%+$8K
April 29, 2019BUY$341.33+103.74%+$8K
November 8, 2018SELL$360.36+92.98%
November 5, 2018SELL$352.02+97.55%
October 18, 2018BUY$391.98+77.41%+$133K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & REGN trading FAQ

Is it legal for Michael T. McCaul to trade Regeneron Pharmaceuticals Inc (REGN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul buy REGN?

Michael T. McCaul disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on December 27, 2013, according to public STOCK Act filings.

How has REGN performed since Michael T. McCaul's trade?

Since Michael T. McCaul bought REGN on December 27, 2013, the stock is up +153.09%, versus +388.48% for the S&P 500 over the same period, an outperformance of -235.39%.

How many times has Michael T. McCaul traded REGN?

Michael T. McCaul has disclosed 65 REGN trades since 2013 (46 purchases and 19 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional REGN trades?

Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncMichael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.